VIVOLTA and Fibrothelium partner to manufacture SimplySilk® membrane for Guided Bone Regeneration
VIVOLTA, the medical electrospinning solutions provider, has signed a long-term partnership with Fibrothelium, a specialist in silk protein biomaterials, to manufacture electrospun components for use in Fibrothelium’s SimplySilk® membrane – an advanced electrospun silk membrane designed to support guided bone regeneration (GBR) in oral surgery.
VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain
VIVOLTA, the medical electrospinning solutions provider, has signed a long-term partnership with Neurochase, the CNS (central nervous system) delivery platform specialist, to manufacture electrospun micro-catheters to deliver advanced therapies to the brain.
VIVOLTA Strengthens Leadership Team With New CEO and New Chairman to Drive Next Phase of Growth
VIVOLTA, a leading global player in the contract development and manufacturing of electrospun medical products, is pleased to announce key appointments to its leadership team as part of its commitment to driving innovation and continued growth.
Avelo, VIVOLTA, and BLINK Win €1.5M Eurostars Grant to Develop New Solution for Diagnosing Lower Respiratory Tract Infections
Avelo, VIVOLTA, and BLINK today announced they have won a €1.5M Eurostars grant to develop a new solution for diagnosing lower respiratory tract infections (LRTIs).
VIVOLTA Raises €7 Million Financing to Further Execute Its Growth Strategy as Medical Electrospinning CDMO
VIVOLTA, a world leader in the development and manufacturing of electrospun medical products, today announced that it has raised €7M in a new funding round with participation from existing shareholders and the Dutch government's NXTGEN HIGHTECH growth fund.
